Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Myriad Genetics Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- −8 vs. Q2 2022
- Shares held
- 81.5M
- +1.59M (+2.0%) vs. Q2 2022
- Total value
- $1.55B
- +$99.6M (+6.8%) vs. Q2 2022
- New holders
- 19
- 73 more added
- Sold out
- 27
- 59 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Duality Advisers, LP | 0 | $0 | 0.00% | −21,188−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,025−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −15,662−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −12,610−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −12,446−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −5,272−100.0% | Sold out |
| First Bank & Trust | 0 | $0 | 0.00% | −5,159−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1,333−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −804−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −398−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −303−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Sageworth Trust Co of South Dakota | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −24−100.0% | Sold out |